Molecular and Cellular Biology · 1988 · 137 citations · 52 references
MedicineMolecular BiologyOncologyMolecular OncologyOncogenesSignal TransductionOncogene ActivationOncogene MutationsOncogenic Signaling PathwaysProtein PhosphorylationProto-oncogene ActivationReceptor Tyrosine Kinase OncogenesLigand-induced Receptor ActivationPoint Mutation EffectsProtein Tyrosine PhosphorylationProto-oncogene MutationReceptor Tyrosine Kinase ActivationReceptor-ligand BindingTransmembrane ProteinsTyrosine Phosphorylation Signaling
p185, the product of the neu/erbB2 proto-oncogene, is oncogenically activated by a point mutation that substitutes glutamic acid for valine in the transmembrane domain of the protein. We have found that the transforming form of p185 differs from its normal counterpart in inducing increased tyrosine phosphorylation of other proteins in vivo and in having a much shorter half-life. These results support the model that the transforming p185 resembles a ligand-activated receptor.
52
Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
Tadashi Yamamoto, Shuntaro Ikawa, Tetsu Akiyama et al. · Nature · 1986 · 1.2K citations
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
Alan L. Schechter, David F. Stern, Lalitha Vaidyanathan et al. · Nature · 1984 · 1.2K citations